Skip to main content
TDR: For Research on Diseases of Poverty

Access

  • Home Alt+0
  • Navigation Alt+1
  • Content Alt+2

Navigation

  • Home
  • About us
  • Research
  • Capacity building
  • Grants
  • Publications
    & resources
  • Partnerships
    & networks
  • Diseases
    & topics
  • News
    & events

Research on neglected priority needs, including product R&D, evaluation in real life settings, and increasing access to new tools

Developing research leadership through education, training, networks and quality management

Assessing global research needs and priorities, providing knowledge management and support for partner coordination

All the calls for research and training grants, career development fellowships and how to apply

Read, download or order TDR's publications and multimedia resources

For the latest news, press releases and TDR events

For more on TDR's strategy, governance, history and to find our staff

For more on TDR partnerships and networks

Search

Advanced search

Subnavigation

  • News and events
  • Latest news
  • TDR events
  • External events

Local production can improve access to medicines, vaccines and diagnostics

A new WHO report provides a framework and analysis

TDR news item
7 December 2011

Producing quality medicines, vaccines and diagnostic tests locally is one way low and middle-income countries can improve people's access to them, as is highlighted in a series of new reports released by the World Health Organization (WHO) in Brussels today.

"This is the first study of this type that seeks to analyse how industry, trade and health policies can work together towards shared goals to both further economic development and improve public health." said Dr Marie-Paule Kieny, Assistant Director General for Innovation, Information, Evidence and Research at WHO.

The study highlights the challenge governments face in balancing the availability of quality-assured medical products that meet priority public health needs with ensuring that products are acceptable and affordable. Imports of affordable medicines, often generics manufactured in India and China, are one solution but the reports highlight a growing trend towards domestic production. The authors bring together evidence from a wide range of countries that are building a viable local manufacturing industry.

For more information contact: Robert Terry.

Share
Email Twitter Facebook Google Delicious LinkedIn
More...
Print

Related links

  • Public health, innovation, and intellectual property

You are here:

  • TDR
  • News and events
  • 2011 News and press releases
  • © WHO 2013
  • More about our sponsors
  • Contact us

Special Programme for Research and Training in Tropical Diseases (TDR)